An interventional study of Blood Flow Restricted Low-Load Resistance Training (BFR-LLRT) and Neuromuscular Training (NMT) in Knee Osteoarthritis (KOA), sponsored by University of Lahore. Enrolling by invitation at 1 site in Pakistan. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University of Lahore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 135 studies in Osteoarthritis, Knee with a site in Pakistan — 41 open to participants now, 50 under way, none of them phase 3. Osteoarthritis, Knee · Pakistan.
Among the 135 studies in Osteoarthritis, Knee with a site in Pakistan, this one has the largest planned enrollment of the 131 interventional ones that give a count, is one of 22 that started in 2026, is one of 130 with no phase, reaches primary completion later than 45 of the 49 other live ones, and was the 135th registered.
3,295 studies on the registry are indexed under Osteoarthritis, Knee; 624 are open to participants now.
Browse Osteoarthritis, Knee studies →41 of the 135 studies in Osteoarthritis, Knee with a site in Pakistan are open now. Recruiting first, the newest first:
Riphah International University · Sites in Pakistan
Ages 40–70
Shifa Tameer-e-Millat University · Sites in Pakistan
Ages 40–60
Riphah International University · Sites in Pakistan
Ages 45–75
University of Lahore · Sites in Pakistan
Ages 40–60
Riphah International University · Sites in Pakistan
Ages 40–65 · Healthy volunteers
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 383 Osteoarthritis, Knee studies recruiting now, 177 (46%) set no upper age limit and 113 (30%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 40 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
135 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 22 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 202 is above the median of 68 across 2,717 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 44 across the 131 interventional studies, 94 across the 4 observational. Of the 81 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 135 has an industry lead sponsor. The 10 most frequent:
University of Lahore is the lead sponsor of 235 studies on the registry; 45 are open to participants now.
University of Lahore has 9 studies filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
10 of the studies in Osteoarthritis, Knee with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07733518Riphah International UniversityEccentric vs Low-Load Blood Flow Restriction Training in Knee Osteoarthritis in Knee Osteoarthritis | 2026-12-21 |
| NCT07913295University of Management and Technology LahoreComparative Effect of Dual Task Training and Rhythmic Stabilization in Knee Osteoarthritis Patients | 2026-12-31 |
| NCT07892144University of Management and Technology LahoreEffects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis (BFR) | 2026-12-31 |
| NCT07908589University of Management and Technology LahoreTempo-controlled Low-load Resistance Training in Patients With Knee Osteoarthritis. | 2026-12-31 |
| NCT07402447Riphah International UniversityEffect of Combined Quadriceps and Calf Strengthening Program on Gait in Knee Osteoarthritis Patients | 2026-12-31 |
Add all 10 to your calendar (.ics) → With an account.
Among the 135 studies in Osteoarthritis, Knee with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to evaluate the effects of blood-flow restricted low-load resistance training combined with neuromuscular training on pain intensity, quadriceps muscle endurance, and quality of life in adults aged 40-75 years with knee osteoarthritis (Kellgren-Lawrence Grade II-III). A total of 202 participants will be allocated into two groups: an experimental group receiving combined BFR and neuromuscular training, and a control group receiving neuromuscular training alone. The intervention will be conducted three times weekly for four weeks. Outcomes will be assessed at baseline, week 2, and week 4 using the Visual Analog Scale (VAS), Repetition-to-Failure Test, and Knee Injury and Osteoarthritis Outcome Score (KOOS). The study aims to determine whether the combined intervention provides greater improvements in pain, muscle endurance, and quality of life.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults aged 40-75 years with a clinical and radiographic diagnosis of knee osteoarthritis (Kellgren-Lawrence grade II-III) - to capture moderate, conservatively manageable OA where BFRT is most beneficial. (He et al., 2025)
(Jardim et al., 2022a)
(He et al., 2025)
Exclusion Criteria:
Peripheral vascular disease or varicose veins, which may impair venous return during BFR (Fontanet et al., 2025)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive supervised neuromuscular training three times per week on alternate days (Monday, Wednesday, and Friday) for four consecutive weeks. Each session will last approximately 40 minutes and include a 5-minute warm-up, balance and proprioception exercises (single-leg stance), strength and motor control exercises (mini-squats, step-downs, and terminal knee extensions using resistance bands), dynamic stability and functional activities (side-stepping, forward lunges, weight-shifting, and sit-to-stand exercises), followed by cool-down stretching. Exercises will be performed under the supervision of a qualified physiotherapist.
Behavioral: Blood Flow Restricted Low-Load Resistance Training (BFR-LLRT) · Behavioral: Neuromuscular Training (NMT)
Participants will receive blood-flow restricted low-load resistance training combined with neuromuscular training three times per week on alternate days for four consecutive weeks. A non-pneumatic elastic strap will be applied to the proximal thigh to partially restrict venous return. Participants will perform seated knee extensions and seated leg curls at 30% of one-repetition maximum (1RM), using one set of 30 repetitions followed by three sets of 15 repetitions, with 30-second rest intervals. Following the blood-flow restriction component, participants will perform the same neuromuscular training protocol as the comparator group, including balance, proprioception, strength, coordination, and functional stability exercises. All sessions will be supervised by a qualified physiotherapist with appropriate safety monitoring.
Behavioral: Blood Flow Restricted Low-Load Resistance Training (BFR-LLRT) · Behavioral: Neuromuscular Training (NMT)
Blood-flow restricted low-load resistance training will be performed using a non-pneumatic elastic strap applied to the proximal thigh to partially restrict venous return. The strap will be tightened to a perceived pressure of 7/10, corresponding to approximately 60-80% arterial occlusion pressure. Participants will perform seated knee extensions and seated leg curls at 30% of one-repetition maximum (1RM), consisting of one set of 30 repetitions followed by three sets of 15 repetitions, with 30-second rest intervals. The cuff will be released between exercises for reperfusion. Training will be supervised by a qualified physiotherapist three times per week for four weeks.
Neuromuscular training will consist of structured exercises designed to improve knee joint proprioception, balance, coordination, and functional stability. The protocol will include single-leg stance on firm and unstable surfaces, mini-squats, step-downs, terminal knee extensions using resistance bands, side-stepping, forward lunges, weight-shifting drills, and sit-to-stand exercises. Sessions will include warm-up and cool-down activities and will be conducted under the supervision of a qualified physiotherapist three times per week for four consecutive weeks, with approximately 40 minutes per session.
Change in Pain Intensity Measured by Visual Analog Scale (VAS)
Time frame: Baseline (Week 0), Week 2, and Week 4 after intervention.
Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.
Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 2 months is below that.
Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.